To facilitate the exchange of information among the global community of dermatologists, the XIth Congress of International Society of Dermatology was held in New Delhi between December 4-7, 2013. A number of oustanding speakers discussed the state of the art in vitiligo management, such as Professors Jana Hercogova, Torello Lotti, Paulo Cunha, Koushik Lahiri, Somesh Gupta, Kanika Sahni, T Salim, Davinder Parsad, among many. Yan Valle, the VR Foundations CEO, gave a detailed presentation on our multidisciplinary approach to an expedited development of drugs for the treatment of vitiligo.
- Polypodium leucotomos as an adjunct treatment for vitiligo?
Extracts of the tropical fern Polypodium leucotomos appear to have beneficial properties for the vitiligious skin. Polypodium leucotomos (also classified as Polypodium aureum) a...
- What is vitiligo?
Vitiligo (pronounced vit-ill-EYE-go) is a generally unpredictable skin disease that causes a gradual loss of skin color and overlying hair on different parts of the body. Cont...
- Vitiligo and hearing loss: any connection?
In short, NO. Recent research shows no relationship between a degree of skin depigmentation and hearing loss severity in vitiligo patients. The results of this study showed tha...
Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.Copyright (C) Bodolóczki Júlia
By taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.